Showing 1 - 20 results of 23 for search 'Stefan Barth', query time: 0.06s
Refine Results
-
1
Symmetry Breakdown Related Fracture in 42CrMo4 Steel by Jian Feng, Stefan Barth, Marc Wettlaufer
Published 2021-02-01
Article -
2
-
3
-
4
-
5
Improving the Therapeutic Potential of Human Granzyme B for Targeted Cancer Therapy by Georg Melmer, Stefan Barth, Nina Berges, Grit Hehmann-Titt, Sonja Schiffer
Published 2013-01-01
Article -
6
Human Cytolytic Fusion Proteins: Modified Versions of Human Granzyme B and Angiogenin Have the Potential to Replace Bacterial Toxins in Targeted Therapies against CD64+ Diseases by Nina Berges, Grit Hehmann-Titt, Dmitrij Hristodorov, Georg Melmer, Theo Thepen, Stefan Barth
Published 2014-02-01
Article -
7
-
8
Human Granzyme B Based Targeted Cytolytic Fusion Proteins by Precious Hlongwane, Neelakshi Mungra, Suresh Madheswaran, Olusiji A. Akinrinmade, Shivan Chetty, Stefan Barth
Published 2018-06-01
Article -
9
Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects. by Musalula Sinkala, Krupa Naran, Dharanidharan Ramamurthy, Neelakshi Mungra, Kevin Dzobo, Darren Martin, Stefan Barth
Published 2024-01-01
Article -
10
Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins by Mehmet Kemal Tur, Adebukola K. Daramola, Stefan Gattenlöhner, Marco Herling, Shivan Chetty, Stefan Barth
Published 2017-10-01
Article -
11
-
12
-
13
Human MAP Tau Based Targeted Cytolytic Fusion Proteins by Olusiji A. Akinrinmade, Sandra Jordaan, Dmitrij Hristodorov, Radoslav Mladenov, Neelakshi Mungra, Shivan Chetty, Stefan Barth
Published 2017-06-01
Article -
14
Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages by Theo Thepen, Stefan Barth, Rainer Fischer, Michael Huhn, Radoslav Mladenov, Eric Aslanian, Dmitrij Hristodorov, Sonja Schiffer
Published 2013-01-01
Article -
15
AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy by Ridhwaanah Jacobs, Makafui Dennis Dogbey, Njabulo Mnyandu, Keila Neves, Stefan Barth, Patrick Arbuthnot, Mohube Betty Maepa
Published 2023-12-01
Article -
16
Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation by Anna Bochicchio, Sandra Jordaan, Valeria Losasso, Shivan Chetty, Rodrigo Casasnovas Perera, Emiliano Ippoliti, Stefan Barth, Paolo Carloni
Published 2017-02-01
Article -
17
Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins. by Diana Klose, Mira Woitok, Judith Niesen, Roger R Beerli, Ulf Grawunder, Rainer Fischer, Stefan Barth, Rolf Fendel, Thomas Nachreiner
Published 2017-01-01
Article -
18
Antibody–siRNA conjugates (ARC): Emerging siRNA drug formulation by Weiran Cao, Rui Li, Xing Pei, Meihong Chai, Lu Sun, Yuanyu Huang, Jiancheng Wang, Stefan Barth, Fei Yu, Huining He
Published 2022-09-01
Article -
19
-
20
Using the SNAP-Tag technology to easily measure and demonstrate apoptotic changes in cancer and blood cells with different dyes. by Mira Woitok, Elena Grieger, Olusiji A Akinrinmade, Susanne Bethke, Anh Tuan Pham, Christoph Stein, Rolf Fendel, Rainer Fischer, Stefan Barth, Judith Niesen
Published 2020-01-01
Article